Diabetes Research and Clinical Practice
Volume 68, Issue 2 , Pages 111-116 , May 2005

CTLA-4 +49 A/G polymorphism is associated with predisposition to type 1 diabetes in Iranians

  • Zahra Mojtahedi

      Affiliations

    • Department of Immunology and Shiraz Institute for Cancer Research, Shiraz University of Medical Sciences, P.O. Box: 71345-1798, Shiraz, Iran
    • ,
  • Gholamhossein R. Omrani

      Affiliations

    • Endocrine and Metabolism Research Center, Namazi Hospital, Shiraz, Iran
    • ,
  • Mehrnoosh Doroudchi

      Affiliations

    • Department of Immunology and Shiraz Institute for Cancer Research, Shiraz University of Medical Sciences, P.O. Box: 71345-1798, Shiraz, Iran
    • ,
  • Abbas Ghaderi

      Affiliations

    • Department of Immunology and Shiraz Institute for Cancer Research, Shiraz University of Medical Sciences, P.O. Box: 71345-1798, Shiraz, Iran
    • Corresponding Author InformationCorresponding author. Tel.: +98 711 230 3687; fax: +98 711 230 4952.

Received 1 July 2004 ,Revised 1 August 2004 ,Accepted 16 August 2004.

References 

  1. Raman K, Mohan C. Genetic underpinnings of autoimmunity—lessons from studies in arthritis, diabetes, lupus and multiple sclerosis. Curr. Opin. Immunol. 2003;15:651–659
  2. Redondo MJ, Eisenbarth GS. Genetic control of autoimmunity in Type I diabetes and associated disorders. Diabetologia. 2002;45:605–622
  3. Field LL. Genetic linkage and association studies of Type I diabetes: challenges and rewards. Diabetologia. 2002;45:21–35
  4. Ihara K, Ahmed S, Nakao F, et al. Association studies of CTLA-4, CD28, and ICOS gene polymorphisms with type 1 diabetes in the Japanese population. Immunogenetics. 2001;53:447–454
  5. Takahashi T, Tagami T, Yamazaki S, et al. Immunologic self-tolerance maintained by CD25(+)CD4(+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. J. Exp. Med. 2000;192:303–310
  6. Read S, Malmstrom V, Powrie F, Cytotoxic . T lymphocyte-associated antigen 4 plays an essential role in the function of CD25(+)CD4(+) regulatory cells that control intestinal inflammation. J. Exp. Med. 2000;192:295–302
  7. Greenwald RJ, Latchman YE, Sharpe AH. Negative co-receptors on lymphocytes. Curr. Opin. Immunol. 2002;14:391–396
  8. Riley JL, Blair PJ, Musser JT, et al. ICOS costimulation requires IL-2 and can be prevented by CTLA-4 engagement. J. Immunol. 2001;166:4943–4948
  9. Lee KM, Chuang E, Griffin M, et al. Molecular basis of T cell inactivation by CTLA-4. Science. 1998;282:2263–2266
  10. Chikuma S, Imboden JB, Bluestone JA. Negative regulation of T cell receptor-lipid raft interaction by cytotoxic T lymphocyte-associated antigen 4. J. Exp. Med. 2003;197:129–135
  11. Krummel MF, Allison JP. CTLA-4 engagement inhibits IL-2 accumulation and cell cycle progression upon activation of resting T cells. J. Exp. Med. 1996;183:2533–2540
  12. Gribben JG, Freeman GJ, Boussiotis VA, et al. CTLA4 mediates antigen-specific apoptosis of human T cells. Proc. Natl. Acad. Sci. USA. 1995;92:811–815
  13. Gavin M, Rudensky A. Control of immune homeostasis by naturally arising regulatory CD4+ T cells. Curr. Opin. Immunol. 2003;15:690–696
  14. Waterhouse P, Penninger JM, Timms E, et al. Lymphoproliferative disorders with early lethality in mice deficient in ctla-4. Science. 1995;270:10985–10988
  15. Maurer M, Loserth S, Kolb-Maurer A, et al. A polymorphism in the human cytotoxic T-lymphocyte antigen 4 (CTLA4) gene (exon 1 +49) alters T-cell activation. Immunogenetics. 2002;54:1–8
  16. Kouki T, Sawai Y, Gardine CA, Fisfalen ME, Alegre ML, DeGroot LJ. CTLA-4 gene polymorphism at position 49 in exon 1 reduces the inhibitory function of CTLA-4 and contributes to the pathogenesis of Graves’ disease. J. Immunol. 2000;165:6606–6611
  17. Ligers A, Teleshova N, Masterman T, Huang WX, Hillert J. CTLA-4 gene expression is influenced by promoter and exon 1 polymorphisms. Genes. Immun. 2001;2:145–152
  18. Marron MP, Raffel LJ, Garchon HJ, et al. Insulin-dependent diabetes mellitus (IDDM) is associated with CTLA4 polymorphisms in multiple ethnic groups. Hum. Mol. Genet. 1997;6:1275–1282
  19. Kikuoka N, Sugihara S, Yanagawa T, et al. Cytotoxic T lymphocyte antigen 4 gene polymorphism confers susceptibility to type 1 diabetes in Japanese children: analysis of association with HLA genotypes and autoantibodies. Clin. Endocrinol (Oxf). 2001;55:597–603
  20. Auwera BJ, Vandewalle CL, Schuit FC, et al. CTLA-4 gene polymorphism confers susceptibility to insulin-dependent diabetes mellitus (IDDM) independently from age and from other genetic or immune disease markers. Clin. Exp. Immunol. 1997;110:98–103
  21. Abe T, Takino H, Yamasaki H, et al. CTLA-4 gene polymorphism correlates with the mode of onset and presence of ICA512 Ab in Japanese type 1 diabetes. Diabetes Res. Clin. Pract. 1999;46:169–175
  22. Takara M, Komiya I, Kinjo Y, et al. Association of CTLA-4 gene A/G polymorphism in Japanese type 1 diabetic patients with younger age of onset and autoimmune thyroid disease. Diabetes Care. 2000;23:975–978
  23. Donner H, Rau H, Walfish PG, et al. CTLA4 alanine-17 confers genetic susceptibility to Graves’ disease and to type 1 diabetes mellitus. J. Clin. Endocrinol. Metab. 1997;82:143–146
  24. Nistico L, Buzzetti R, Pritchard LE, et al. The CTLA-4 gene region of chromosome 2q33 is linked to, and associated with, type 1 diabetes. Belgian Diabetes Registry. Hum. Mol. Genet. 1996;5:1075–1080
  25. National Diabetes Data Group, Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance, Diabetes 28 (1979) 1039–1057.
  26. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988;16:1215
  27. Bourn D, Carter SA, Mason S, Gareth D, Evans R, Strachan T. Germline mutations in the neurofibromatosis type 2 tumour suppressor gene. Hum. Mol. Genet. 1994;3:813–816
  28. Kallmann BA, Huther M, Tubes M, et al. Systemic bias of cytokine production toward cell-mediated immune regulation in IDDM and toward humoral immunity in Graves’ disease. Diabetes. 1997;46:237–243
  29. Kallmann BA, Lampeter EF, Hanifi-Moghaddam P, Hawa M, Leslie RD, Kolb H. Cytokine secretion patterns in twins discordant for Type I diabetes. Diabetologia. 1999;42:1080–1085
  30. Jun H, Yoon JW. The role of viruses in type I diabetes: two distinct cellular and molecular pathogenic mechanisms of virus-induced diabetes in animals. Diabetologia. 2001;44:271–285
  31. Ueda H, Howson JM, Esposito L, et al. Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature. 2003;423:506–511
  32. Xu Y, Graves PN, Tomer Y, Davies TF. CTLA-4 and autoimmune thyroid disease: lack of influence of the A49G signal peptide polymorphism on functional recombinant human CTLA-4. Cell. Immunol. 2002;215:133–140
  33. Zipris D, Hillebrands JL, Welsh RM, et al. Infections that induce autoimmune diabetes in BBDR rats modulate CD4+CD25+ T cell populations. J. Immunol. 2003;170:3592–3602
  34. Carl CF, Hoffman WH, Blankenship PR, Litaker MS, Hoffman MG, Mabe PA. Diabetic ketoacidosis depletes plasma tryptopha. Endocr. Res. 2002;28:91–102

PII: S0168-8227(04)00285-2

doi: 10.1016/j.diabres.2004.08.008

Diabetes Research and Clinical Practice
Volume 68, Issue 2 , Pages 111-116 , May 2005

Article Tools